Drawing for TERAFRONT

USPTO serial 79456087

TERAFRONT

Reviewed by CopyMark Law Group

Status 640Office Action
Filing date
Status date
Registration date
—
Examiner
HUDSON, TAMARA BREE
Law office
TMEG LAW OFFICE 104

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 640: Status 640 means the examining attorney has prepared a non-final Office Action but it has not been mailed or e-mailed yet. The action should appear in TSDR soon, and a response deadline will start once it is issued.

Need help with TERAFRONT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical products for medical and veterinary use, namely injectable pharmaceutical products and pharmaceutical products in solid form; hygienic and sanitary products for medical use; dietetic foods and nutritional supplements for medical or veterinary use, namely food for babies, nutritional supplements for humans, nutritional supplements for animals; plasters, namely adhesive bandages, medical dressings; materials for dental fillings; dental impression materials; all-purpose disinfectants; preparations for destroying vermin; fungicides for medical use; biological herbicides; antibiotics; pain relief medication; anesthetics for surgical and non-surgical use; amino acids for medical use; antiseptic preparations; anxiolytics; eye drops; digestives for pharmaceutical use; laxatives; prescription synthetic narcotics; chemical products for pharmaceutical and veterinary purposes; chemico-pharmaceutical products; restorative products for medical use; sedatives; soporifics in the form of tablets; pharmaceutical and medicinal products, namely medicinal serums; pharmaceutical and medicinal products, namely vaccines; syringes sold filled with injectable pharmaceutical products; unit-dose capsules filled with pharmaceutical productsACTIVE—
042Scientific and technological services, specifically scientific testing and analysis of pharmaceutical and medical products in the pharmaceutical field; scientific research and design services in the field of pharmaceutical products; scientific research in the pharmaceutical field; industrial analysis and research services in the field of pharmaceutical and medical products; hardware and software design and development; research and development of new products for third parties; scientific research for new pharmaceutical products; development of pharmaceutical products; bacteriological research; biological research; geological research; chemical research; technical research in the field of pharmaceutical studies; technical research in the field of medical studies; conducting feasibility studies in the field of pharmaceutical and medical products; quality control services for goods and services; authentication services in the field of pharmaceutical and medical products; chemical analysis; testing of new products for third parties; testing of chemical products; scientific research consisting in conducting clinical trials for third parties; quality control for manufactured products; quality evaluation of pharmaceutical productsACTIVE—
044Medical services; veterinary services; hygienic and beauty care services for persons; hygienic and beauty care services for animals; advisory and consultancy services relating to agriculture, horticulture and forestry; pharmaceutical advice; information and consultation services via the Internet regarding pharmaceutical products; drug testing service for medical use, namely drug analysis for medical diagnostic or treatment purposes; pharmacist services for filling prescriptions; medical analysis services relating to the treatment of people; consulting services in the field of pharmaceutical productsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 3, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 2, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 23, 2026DOCKASSIGNED TO EXAMINER—
Aug 28, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 28, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 27, 2026LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Aug 13, 2026REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance